Catalyst Wire Dossier Catalyst Wire Dossier

B1344 Injection

B1344 · Tasly Biopharmaceuticals Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for B1344 Injection, covering 2025-08-19 to 2025-08-19. Get the full timeline:

Most recent: Clinical Trial Update: a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) [Phase 1]

See pricing